Tgif2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses thereof

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP14177287.1

公开号：

EP2975116A1

申请日:

2014.07.16

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The invention relates to genetically modified human pancreatic progenitor cells, comprising an exogenous nucleic acid molecule encoding TGIF2, for use as a medicament in the treatment of a subject with diabetes, in addition to methods for the production of said cells. The invention also comprises an expression vector encoding TGIF2 for use as a medicament in the treatment of a subject with diabetes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/